Stock Taper Total Revenue: $257.5 million, up 6.6% year-over-year, marking the highest revenue quarter in 15 quarters.
Adjusted EBITDA: $155.8 million, representing 60.5% of revenue, the strongest performance in 13 quarters.
Operating Cash Flow: $93 million, up 51% year-over-year.
Unlevered Free Cash Flow: $89.5 million, up 24% year-over-year.
Levered Free Cash Flow: $54.6 million, up 49% year-over-year.
Bookings: $30 million in Q2, with a total of $74 million for the first half of 2026, on track to exceed the $100 million target for the full year.
The company is executing a turnaround strategy focused on sustainable growth, particularly in the third-party administrator (TPA) market, which contributed significantly to Q2 bookings.
Claritev is investing in technology modernization and AI capabilities to enhance service delivery and operational efficiency.
The Claims Intelligence service line saw a notable 14% increase in Q2, driven by the No Surprises Act (NSA) business.
The company is diversifying its offerings, with a growing presence in Medicare Advantage and public sector deals.
Revenue Guidance: Raised to $1 billion to $1.02 billion for 2026, reflecting 4% to 6% growth.
Adjusted EBITDA Guidance: Increased to $610 million to $620 million.
Free Cash Flow Guidance: Adjusted to a range of $5 million to $15 million.
The company expects continued investment in sales and marketing to support growth, with new bookings taking 2 to 4 quarters to convert to revenue.
The network segment is projected to decline due to a prior year’s one-time revenue impact, which may affect year-over-year comparisons.
The company is managing a conservative outlook for claims volumes, particularly in the second half of the year, which could impact revenue.
The competitive environment remains challenging, with ongoing regulatory complexities and pricing pressures in the healthcare sector.
Claims Volume Dynamics: Management indicated that Q2's claims volume was influenced by a temporary surge and expects a modest decline moving forward.
Revenue Recognition Timing: New bookings typically take 2 to 4 quarters to convert into revenue, with some larger wins converting faster than anticipated.
AI Initiatives: The company has identified over $1 billion in additional savings through AI initiatives, indicating a strong focus on leveraging technology for operational improvements.
NSA Revenue: The uptick in NSA-related revenue is primarily from a significant client win, with expectations for continued growth as new regulations are implemented. Overall, Claritev Corporation reported strong financial performance in Q2 2026, driven by strategic investments and a focus on technology and operational efficiency, while navigating challenges in the healthcare landscape.
SOURCE: Q2 2026 EARNINGS CALL TRANSCRIPT